Publication | Open Access

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial

Rheumatoid DisorderRheumatologyAutoimmune DiseaseWeek 16Rheumatic DiseasesMulticenter Carera TrialEarly Rheumatoid ArthritisInflammatory Rheumatic DiseaseMedicineRheumatoid Arthritis